Protara Therapeutics Stock Market Value
| TARA Stock | USD 7.08 0.08 1.14% |
| Symbol | Protara |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protara Therapeutics. If investors know Protara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Protara Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Protara Therapeutics requires distinguishing between market price and book value, where the latter reflects Protara's accounting equity. The concept of intrinsic value—what Protara Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Protara Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Protara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Protara Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Protara Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Protara Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Protara Therapeutics.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Protara Therapeutics on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Protara Therapeutics or generate 0.0% return on investment in Protara Therapeutics over 90 days. Protara Therapeutics is related to or competes with NeOnc Technologies, Invivyd, Codexis, Mediwound, Sellas Life, OmniAb, and Orchestra BioMed. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transfo... More
Protara Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Protara Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Protara Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.42 | |||
| Information Ratio | 0.0982 | |||
| Maximum Drawdown | 39.96 | |||
| Value At Risk | (8.67) | |||
| Potential Upside | 11.78 |
Protara Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Protara Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Protara Therapeutics' standard deviation. In reality, there are many statistical measures that can use Protara Therapeutics historical prices to predict the future Protara Therapeutics' volatility.| Risk Adjusted Performance | 0.0874 | |||
| Jensen Alpha | 0.6295 | |||
| Total Risk Alpha | 0.2194 | |||
| Sortino Ratio | 0.1107 | |||
| Treynor Ratio | 1.56 |
Protara Therapeutics January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0874 | |||
| Market Risk Adjusted Performance | 1.57 | |||
| Mean Deviation | 4.04 | |||
| Semi Deviation | 4.79 | |||
| Downside Deviation | 5.42 | |||
| Coefficient Of Variation | 924.01 | |||
| Standard Deviation | 6.11 | |||
| Variance | 37.29 | |||
| Information Ratio | 0.0982 | |||
| Jensen Alpha | 0.6295 | |||
| Total Risk Alpha | 0.2194 | |||
| Sortino Ratio | 0.1107 | |||
| Treynor Ratio | 1.56 | |||
| Maximum Drawdown | 39.96 | |||
| Value At Risk | (8.67) | |||
| Potential Upside | 11.78 | |||
| Downside Variance | 29.33 | |||
| Semi Variance | 22.96 | |||
| Expected Short fall | (4.67) | |||
| Skewness | 0.5897 | |||
| Kurtosis | 3.14 |
Protara Therapeutics Backtested Returns
Protara Therapeutics appears to be slightly risky, given 3 months investment horizon. Protara Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. By analyzing Protara Therapeutics' technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please evaluate Protara Therapeutics' Semi Deviation of 4.79, risk adjusted performance of 0.0874, and Coefficient Of Variation of 924.01 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Protara Therapeutics holds a performance score of 9. The company holds a Beta of 0.42, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Protara Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Protara Therapeutics is expected to be smaller as well. Please check Protara Therapeutics' expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Protara Therapeutics' historical price patterns will revert.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Protara Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Protara Therapeutics time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Protara Therapeutics price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Protara Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.45 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Protara Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Protara Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Protara Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Protara Therapeutics Stock:Check out Protara Therapeutics Correlation, Protara Therapeutics Volatility and Protara Therapeutics Performance module to complement your research on Protara Therapeutics. For information on how to trade Protara Stock refer to our How to Trade Protara Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Protara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.